Mark Cuban's Cost Plus Drugs Gets Medication Elon Musk Asked About 6 Months Ago: 'Still Ready To Save Tesla, SpaceX And X a F**kton of Money'
Portfolio Pulse from Shanthi Rexaline
Mark Cuban's Cost Plus Drugs now offers Ivermectin, a medication Elon Musk inquired about 6 months ago. Cuban responded to Musk's earlier question on Twitter, highlighting the potential savings for Musk's companies Tesla, SpaceX, and X. Cuban's company aims to reduce drug prices by cutting out middlemen. The price of Ivermectin on Cost Plus Drugs is significantly lower than the average cost listed on WebMDRx. The iShares U.S. Healthcare Providers ETF (IHF) closed up 1.32% recently.
December 14, 2023 | 8:26 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The iShares U.S. Healthcare Providers ETF (IHF) may see investor interest due to the focus on reducing healthcare costs, as exemplified by Mark Cuban's Cost Plus Drugs offering Ivermectin at lower prices. This could be seen as part of a broader trend towards cost efficiency in healthcare.
The news about Cost Plus Drugs offering Ivermectin at a lower cost aligns with the current investor sentiment favoring cost reduction in healthcare. This could lead to a positive perception of the healthcare sector, potentially benefiting ETFs like IHF that track healthcare providers.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 70